First human test for new drug begins
NCT ID NCT07005284
Summary
This is an early-stage study to check the safety of a new drug called LY3981314 and see how the body handles it. It involves about 76 healthy volunteers who will receive a single injection under the skin. The main goal is to identify any side effects and measure the drug's levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel ACT
RECRUITINGAnaheim, California, 92801, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.